A Rare Presentation of Primary Nasopharyngeal Carcinoma (NPC) in Mediastinum

被引:1
|
作者
Fathi, Afshin [1 ]
Amani, Firuz [2 ]
Davoodi, Mohammad [3 ]
Bahadoram, Sara [4 ]
Bahadoram, Mohammad [5 ,6 ]
机构
[1] Ardabil Univ Med Sci, Pediat Haematol Oncol, Fac Med, Ardebil, Iran
[2] Ardabil Univ Med Sci, Biostat & Epidemiol, Ardebil, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Golestan Hosp, Dept Radiol, Ahvaz, Iran
[4] Univ Tehran Med Sci, Dept Pediat, Imam Khomeini Hosp Complex, Tehran, Iran
[5] Ahvaz Jundishapur Univ Med Sci, Med Student Res Comm, Ahvaz, Iran
[6] Ahvaz Jundishapur Univ Med Sci, Social Determinant Hlth Res Ctr, Ahvaz, Iran
关键词
Nasopharyngeal Carcinoma; Radiotherapy Resistant; Neoadjuvant Chemotherapy; Interferon;
D O I
10.17795/ijcp-4277
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Nasopharyngeal carcinoma among the children has been rare accounting for only 1% of all pediatric malignancies. Both genetic and environmental factors have contributed to the development of nasopharyngeal carcinoma. Among the children there was a higher rate of undifferentiated histology. The mean age of nasopharyngeal carcinoma diagnosis has been 11 years old age; and the most common site was nasopharynx. Palpable lymphadenopathy, dysphasia and neural defect were common associated signs. Case Presentation: A 15-year-old boy has presented with a mass that located near by the heart in the left side of mediastinum with invasion to anterior mediastinum from two years ago. In biopsy, nasopharyngeal carcinoma, non-keratinizing type, has diagnosed while there was no involvement of nasopharyngeal region. Patient has treated by 70 Gy (2.0 Gy/fraction) radiotherapy plus concomitant chemotherapy with base of docetaxel. But the mass had no regression. Then, the patient has treated with Cisplatin 100 mg/m(2) IV on days 1, 22, and 43 with radiation, then cisplatin 80 mg/m2 IV on day 1 plus fluorouracil (5-FU) 1000 mg/m(2)/day by continuous IV infusion on days 1 - 4 every 4wk for 3 cycles and after remission interferon beta has added to treatment for 6 months duration as a maintenance therapy. After 1 year follow up; the patient was in complete remission. In the course of therapy, only hypothyroidism has occurred. Conclusions: Nasopharyngeal carcinoma in childhood, without nasopharyngeal involvement, initially could be detected in other sites such as pericardium. Also good results could be respected by cisplatin and 5-fluorouracil based neoadjuvant chemotherapy before radiotherapy plus interferon beta as a maintenance therapy in childhood aggressive nasopharyngeal carcinoma.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Salvage Treatment for Locally Recurrent Nasopharyngeal Carcinoma (NPC)
    Chen, Chuangzhen
    Fee, Willard
    Chen, Jianzhou
    Chan, Cato
    Khong, Brian
    Hara, Wendy
    Goffinet, Don
    Li, Derui
    Quynh-Thu Le
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (04): : 327 - 331
  • [42] Radiology quiz case 1 - Nasopharyngeal carcinoma (NPC)
    Dean, R
    Pitman, K
    Chu, JY
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (06) : 796 - +
  • [44] RECENT ADVANCES IN THE STUDY OF THE PATHOGENESIS OF NASOPHARYNGEAL CARCINOMA (NPC)
    姚开泰
    [J]. 中华医学杂志(英文版), 1995, (08) : 8 - 10
  • [45] PATHOLOGIC AND DEMOGRAPHIC-STUDIES ON NASOPHARYNGEAL CARCINOMA (NPC)
    LEVINE, PH
    EASTON, JM
    HYAMS, VJ
    CONNELLY, RR
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 269 - 269
  • [46] A STUDY OF THE TNM STAGING SYSTEM FOR NASOPHARYNGEAL CARCINOMA (NPC)
    李长青
    廖玲霞
    [J]. Chinese Journal of Cancer Research, 1996, (02) : 148 - 151
  • [47] Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma (NPC)
    Ciuleanu, E
    Ciuleanu, TE
    Popita, V
    Todor, N
    Fodor, A
    Ghilezan, N
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S162 - S162
  • [48] COMPLEX SEGREGATION ANALYSIS OF NASOPHARYNGEAL CARCINOMA (NPC) IN TAIWAN
    WANG, YF
    CHEN, CJ
    HARRIS, EL
    KING, TM
    HSU, MM
    DIEHL, SR
    BEATY, TH
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 995 - 995
  • [49] EPIDEMIOLOGIC, ETIOLOGIC AND IMMUNOLOGICAL ASPECTS OF NASOPHARYNGEAL CARCINOMA [NPC]
    GASTPAR, H
    WILMES, E
    WOLF, H
    [J]. JOURNAL OF MEDICINE, 1981, 12 (04) : 257 - 284
  • [50] EXPERIMENTAL STUDIES ON SPECIFIC IMMUNOTHERAPY IN NASOPHARYNGEAL CARCINOMA (NPC)
    ARNOLD, W
    VOSTEEN, KH
    [J]. ARCHIVES OF OTO-RHINO-LARYNGOLOGY-ARCHIV FUR OHREN-NASEN-UND KEHLKOPFHEILKUNDE, 1980, 229 (01): : 5 - 11